AMR101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AMR101, covering 2022-04-25 to 2022-04-25. Get the full timeline:
Most recent: Clinical Trial Update: Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL) [Phase 3]